ADIAL PHARMACEUTICALS, INC.·3

Jun 29, 12:47 PM ET

Coastlands Capital LP 3

3 · ADIAL PHARMACEUTICALS, INC. · Filed Jun 29, 2026

Insider Transaction Report

Form 3
Period: 2026-06-24
Holdings
  • Common Stock

    [F1]
    (indirect: By Coastlands Capital LP)
    348,322
  • Pre-funded Warrant

    [F2][F1]
    (indirect: By Coastlands Capital LP)
    Exercise: $0.00Common Stock (3,637,818 underlying)
Footnotes (2)
  • [F1]Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 3 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.
  • [F2]The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

Documents

2 files